Histopathology of hepatocellular carcinoma

Recent Results in Cancer Research

Volumn 190, Issue , 2013, Pages 21-32

  Paradis, Valérie ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19; CYTOKERATIN 7; GLUTAMATE AMMONIA LIGASE; GLYPICAN 3; HEAT SHOCK PROTEIN 70;

ARTICLE; CANCER GRADING; CANCER SURVIVAL; CELL DIFFERENTIATION; CHRONIC LIVER DISEASE; DISEASE COURSE; FATTY LIVER; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER HEMORRHAGE; LIVER NECROSIS; LIVER NODULE; MALIGNANT TRANSFORMATION; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROGNOSIS; VIRUS HEPATITIS;

ADENOMA, LIVER CELL; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84868325594     PISSN: 00800015     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-16037-0_2     Document Type: Article

References (59)

1. El-Serag HB (2007) Epidemiology of hepatocellular carcinoma in USA. Hepatol Res 37:S88-S94
2. Nordenstedt H, White DL, El-Serag HB (2010) The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 42:S206-S214
3. Sherman M (2005) Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis 25:143-154 (Pubitemid 40781067)
4. Bosman FT, Carneiro F, Hruban RH et al (2010) WHO classification of tumours of the Digestive System 4th edn. IARC Press, Lyon, pp 322-326
5. Colombo M, de Franchis R, Del Ninno E et al (1991) Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 325:675-680
6. International Working Party (1995) Terminology of nodular hepatocellular lesions. Hepatology 22:983-993
7. Okuda K, Peters RL, Simson IW (1984) Gross anatomic features of hepatocellular carcinoma from three disparate geographic areas: proposal of new classification. Cancer 54:2165-2173 (Pubitemid 15210800)
8. International Consensus Group for Hepatocellular Carcinoma (2009) Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 49:658-664
9. Hytiroglou P, Park YN, Krinsky G et al (2007) Hepatic precancerous lesions and small hepatocellular carcinoma. Gastroenterol Clin North Am 36:867-887 (Pubitemid 350051705)
10. Anthony PP (1973) Primary carcinoma of the liver: a study of 282 cases in Ugandan Africans. J Pathol 110:37-48
11. Omata M, Peters RL, Tatter D (1981) Sclerosing hepatic carcinoma: relationship to hypercalcemia. Liver 1:33-49 (Pubitemid 11015251)
12. Kojiro M, Sugihara S, Kakizoe S et al (1989) Hepatocellular carcinoma with sarcomatous change: a special reference to the relationship with anticancer therapy. Cancer Chemother Pharmacol 23:4-8
13. Shafizadeh N et al (2008) Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum. Modern Pathol 21:1011-1018
14. Wang XY, Degos F, Dubois S et al (2006) Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas. Human Pathol 37:1435-1441 (Pubitemid 44739946)
15. Di Tommaso L, Franchi G, Park YN et al (2007) Diagnostic value of HSP70, Glypican 3 and Glutamine synthetase i hepatocellular nodules in cirrhosis. Hepatology 45:725-737
16. Libbrecht L, Severi T, Cassiman D et al (2006) Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Am J Surg Pathol 30:1405-1411 (Pubitemid 44655475)
17. Chuma M, Sakamoto M, Yamazaki K et al (2003) Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology 37:198-207 (Pubitemid 36042161)
18. Villanueva A, Newell P, Chiang DY et al (2007) Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis 27:55-76
19. Boyault S, Rickman DS, de Reynies A et al (2007) Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 45:42-52 (Pubitemid 46144363)
20. Ladeiro Y, Couchy G, Balabaud C et al (2008) MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47:1955-1963 (Pubitemid 351952843)
21. Villanueva A, Chiang DY, Newell P et al (2008) Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology 135:1972-1983
22. de La Coste A, Romagnolo B, Billuart P et al (1998) Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A 95:8847-8851 (Pubitemid 28350577)
23. Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7:462-503
24. Pawlik TM, Gleisner AL, Anders RA et al (2007) Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility. Ann Surg 245:435-442 (Pubitemid 46673140)
25. Chuong JJ, Livstone EM, Barwick KW (1982) The histopathologic and clinical indicators of prognosis in hepatoma. J Clin Gastroenterol 4:547-552 (Pubitemid 13167837)
26. Lai CL, Wu PC, Lam KC et al (1979) Histologic prognostic indicators in hepatocellular carcinoma. Cancer 44:1677-1683 (Pubitemid 10140394)
27. Nathan H, Schulick RD, Choti MA et al (2009) Predictors of survival after resection of early hepatocellular carcinoma. Ann Surg 249:799-805
28. Pawlik TM, Delman KA, Vauthey JN et al (2005) Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 11:1086-1092 (Pubitemid 41341758)
29. Lee J-S, Chu I-S, Heo J et al (2004) Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 40:667-676 (Pubitemid 39265589)
30. Ferrell L, Wright T, Lake J et al (1992) Incidence and diagnostic features of macroregenerative nodules vs. small hepatocellular carcinoma in cirrhotic livers. Hepatology 16:1372-1381
31. Mion F, Grozel L, Boillot O et al (1996) Adult cirrhotic liver explants: precancerous lesions and undetected small hepatocellular carcinomas. Gastroenterology 111:1587-1592 (Pubitemid 26404223)
32. Takayama T, Makuuchi M, Hirohashi S et al (1990) Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 336:1150-1153 (Pubitemid 20362906)
33. Theise ND, Schwartz M, Miller C et al (1992) Macroregenerative nodules and hepatocellular carcinoma in forty-four sequential adult liver explants with cirrhosis. Hepatology 16:949-955
34. Kojiro M, Roskams T (2005) Early hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis 25:133-142 (Pubitemid 40781066)
35. Theise ND, Park YN, Kojiro M (2002) Dysplastic nodules and hepatocarcinogenesis. Clin Liver Dis 6:497-512 (Pubitemid 34755902)
36. Park YN, Kojiro M, Di Tommaso L et al (2007) Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinoma, and dysplastic nodules. Cancer 109:915-923 (Pubitemid 46333533)
37. Borzio M, Bruno S, Roncalli M et al (1995) Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology 108:812-817
38. Lee RG, Tsamandas AC, Demetris AJ (1997) Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis. Hepatology 26:1415-1422 (Pubitemid 27520005)
39. Lam CM, Chan AO, Ho P et al (2004) Different presentation of hepatitis B-related hepatocellular carcinoma in a cohort of 1863 young and old patients: implications for screening. Aliment Pharmacol Ther 19:771-777 (Pubitemid 38496643)
40. Marrero JA, Fontana RJ, Su GL et al (2002) NAFLD maybeacommon underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 36:1349-1354 (Pubitemid 35403524)
41. Paradis V, Zalinski S, Chelbi E et al (2009) Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology 49:851-859
42. Adams LA, Lymp JF, Sauver JS et al (2005) The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129:113-121 (Pubitemid 41002048)
43. Angulo P (2002) Non alcoloholic fatty liver diseases. New Engl J Med 346:1221-1231 (Pubitemid 34984585)
44. Farrell GC, Larter CZ (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43:S99-S112
45. El-Serag HB, Tran T, Everhart JE (2004) Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126:460-468 (Pubitemid 38182303)
46. Nair S, Mason A, Eason J et al (2002) Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology 36:150-155 (Pubitemid 34700772)
47. Cuadrado A, Orive A, García-Suárez C et al (2005) Non-alcoholic steatohepatitis (Nash) and hepatocellular carcinoma. Obes Surg 15:442-446 (Pubitemid 40463617)
48. Guzman G, Brunt EM, Petrovic LM et al (2008) Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis? Ach Pathol Lab Med 132:1761-1766
49. Kawada N, Imanaka K, Kawaguchi T et al (2009) Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis. J Gastroenterol 44:1190-1194
50. Farges O, Ferreira N, Dokmak S et al (2011) Changing trends in malignant transformation of hepatocellular adenoma. Gut 60:85-89
51. Craig JR, Peters RL, Edmondson HA et al (1980) Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 46:372-379 (Pubitemid 10085954)
52. El-Serag HB, Davila JA (2004) Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology 39:798-803 (Pubitemid 38337660)
53. Van Eyken P, Sciot R, Brock P et al (1990) Abundant expression of cytokeratin 7 in fibrolamellar carcinoma of the liver. Histopathology 17:101-107 (Pubitemid 20258632)
54. Rosenberg L (1991) The risk of liver neoplasia in relation to combined oral contraceptive use. Contraception 43:643-652
55. Socas L, Zumbado M, Pérez-Luzardo O et al (2005) Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Br J Sports Med 39:e27
56. Dokmak S, Paradis V, Vilgrain V et al (2009) A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 137:1698-1705
57. Paradis V, Champault A, Ronot M et al (2007) Telangiectatic adenomas: an entity associated with increased body mass index and inflammation. Hepatology 46:140-146 (Pubitemid 47171930)
58. Bioulac-Sage P, Laumonier H, Couchy G et al (2009) Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 50:481-489
59. Deneve JL, Pawlik TM, Cunningham S et al (2009) Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol 16:640-648